Goodpasture disease: Difference between revisions
No edit summary |
|||
| Line 18: | Line 18: | ||
==[[Goodpasture syndrome causes|Causes]]== | ==[[Goodpasture syndrome causes|Causes]]== | ||
==[[Goodpasture syndrome | ==[[Differentiating Goodpasture syndrome from other diseases|Differentiating Goodpasture syndrome from other Diseases]]== | ||
==[[Goodpasture syndrome epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Goodpasture syndrome epidemiology and demographics|Epidemiology and Demographics]]== | ||
Revision as of 16:36, 8 June 2016
|
Goodpasture syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Goodpasture disease On the Web |
|
American Roentgen Ray Society Images of Goodpasture disease |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Synonyms and keywords: Anti-GBM nephritis with pulmonary hemorrhage; antiglomerular basement membrane disease; Goodpasture’s syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Goodpasture syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related Chapters
External links
GBM antibodies: immunofluorescence image
Template:Diseases of the musculoskeletal system and connective tissue